Literature DB >> 974964

Carrier detection and genetic counselling in Duchenne muscular dystrophy: a follow-up study.

E M Hutton, M W Thompson.   

Abstract

Assay of serum creatine kinase activity is useful in the detection of carriers of the X-linked gene for Duchenne muscular dystrophy (DMD). For genetic counselling this assay has been used in conjunction with pedigree analysis to improve estimates of the risk that a female relative of a DMD patient is a carrier. To measure the impact of the program, follow-up information was obtained from women who had received genetic counselling for DMD. Their responses showed that the risk of producing an affected son had been a major factor in their attitude toward family planning, and their reproductive performance correlated inversely with their genetic risk. The decision by the majority of proven carriers to prevent the birth of further male offspring was reflected in a recent decline in the frequency of a known family history of DMD among newly ascertained cases.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 974964      PMCID: PMC1878853     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  6 in total

1.  A method for the estimation of serum creatine kinase and its use in comparing creatine kinase and aldolase activity in normal and pathological sera.

Authors:  B P HUGHES
Journal:  Clin Chim Acta       Date:  1962-09       Impact factor: 3.786

2.  An improved procedure for serum creatine phosphokinase determination.

Authors:  S B Rosalki
Journal:  J Lab Clin Med       Date:  1967-04

3.  Genetic clinic. A follow-up.

Authors:  C O Carter; J A Roberts; K A Evans; A R Buck
Journal:  Lancet       Date:  1971-02-06       Impact factor: 79.321

4.  The effects of genetic counselling in Duchenne muscular dystrophy.

Authors:  A E Emery; M S Watt; E R Clack
Journal:  Clin Genet       Date:  1972       Impact factor: 4.438

5.  An assessment of the creatine kinase test in the detection of carriers of Duchenne muscular dystrophy.

Authors:  M W Thompson; E G Murphy; P J McAlpine
Journal:  J Pediatr       Date:  1967-07       Impact factor: 4.406

6.  Serum levels of ATP: creatine phosphotransferase (creatine kinase). The normal range and effect of muscular activity.

Authors:  P D Griffiths
Journal:  Clin Chim Acta       Date:  1966-04       Impact factor: 3.786

  6 in total
  9 in total

1.  The periodic health examination. Canadian Task Force on the Periodic Health Examination.

Authors: 
Journal:  Can Med Assoc J       Date:  1979-11-03       Impact factor: 8.262

2.  Toward a new conceptualization and operationalization of risk perception within the genetic counseling domain.

Authors:  C G Palmer; F Sainfort
Journal:  J Genet Couns       Date:  1993-12       Impact factor: 2.537

3.  Are abortions more or less frequent once prenatal diagnosis is available?

Authors:  S Bundey; E Boughton
Journal:  J Med Genet       Date:  1989-12       Impact factor: 6.318

4.  Reproductive patterns among mothers of males diagnosed with Duchenne or Becker muscular dystrophy.

Authors:  Sarah K Nabukera; Paul A Romitti; Kristin M Caspers; Natalie Street; Christopher Cunniff; Katherine D Mathews; Deborah J Fox; Soman Puzhankara; Emma Ciafaloni; Katherine A James; Yin Su
Journal:  Am J Med Genet A       Date:  2012-12-13       Impact factor: 2.802

Review 5.  Duchenne muscular dystrophy: pathogenetic aspects and genetic prevention.

Authors:  H Moser
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

6.  The female carrier of Duchenne muscular dystrophy.

Authors:  V Dubowitz
Journal:  Br Med J (Clin Res Ed)       Date:  1982-05-15

7.  Knowledge of carrier status and barriers to testing among mothers of sons with Duchenne or Becker muscular dystrophy.

Authors:  Lauren Bogue; Holly Peay; Ann Martin; Ann Lucas; Sindhu Ramchandren
Journal:  Neuromuscul Disord       Date:  2016-09-16       Impact factor: 4.296

8.  Epidemiology of Duchenne muscular dystrophy in the province of Turin.

Authors:  A Bertolotto; M De Marchi; C Doriguzzi; T Mongini; C Monnier; L Palmucci; D Schiffer; L Verzé
Journal:  Ital J Neurol Sci       Date:  1981-01

9.  DMD-related muscular dystrophy in Cameroon: Clinical and genetic profiles.

Authors:  Edmond Wonkam-Tingang; Séraphin Nguefack; Alina I Esterhuizen; David Chelo; Ambroise Wonkam
Journal:  Mol Genet Genomic Med       Date:  2020-06-15       Impact factor: 2.473

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.